Oracle (ORCL) has shown significant rallies in its history. In 2025, it experienced more than a 50% increase within two ...

Though it certainly doesn’t feel like it, Oracle (NASDAQ:ORCL) shares finished 2025 with respectable, market-beating gains ...

Oracle’s (NYSE: ORCL) 2025 stock price action might suggest it is a hard pass for 2026, but that would be misreading the ...

Oracle (ORCL) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

Get the live share price of Oracle Corporation (ORCL), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.

Oracle’s ORCL relationship with OpenAI has become a never-ending source of market angst, as the tie-in reminds many of questionable vendor-financing practices from the late 1990s. Tied to Oracle’s ...

A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history.

Throughout 2025, Novo Nordisk (NVO) punished investors. NVO stock closed at $48.10, near its 52-week low of $43.08. In after-hours trading on Monday, the stock gained 9.48%. The U.S. Food and Drug ...

Oracle Corporation faces continued downside risk despite a sharp post-earnings price correction. ORCL's recent expansion is increasingly debt-fueled, with long-term debt nearing $100B and lease ...